Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.

Abstract

The results suggest that MADD itself is unlikely to be solely responsible for the manifestation of muscular symptoms. It is probable that either the loss of a compensation mechanism or coexistent disturbances in muscle metabolism which are unidentified so far are required for the emergence of complaints.